MicroVue™ Mouse PTH ELISA (1-84)

The MicroVue Mouse PTH 1-84 ELISA Kit is for the measurement of PTH in mouse plasma or cell culture media.

Product Specifications

Citations	13
Specimen	Plasma or Cell Culture Supernatent, 25 μL
LLOQ	0.004 ng/mL
ULOQ	N/A
Assay Time	3.5 hours
Cross Reactivity	Rat

Technical Documents

Ordering Information

For Research Use Only. Not for use in diagnostic procedures.

Catalog Number	60-2305
Catalog Number (CE)
Size	96 wells/test
Price (USD)	$725.00
Price (EURO)	640,00 €

Request an Order

Contact us

US Phone	+1 (858) 552 1100
EU Phone	+353 (91) 412 474
US Email	contact-us@quidelortho.com
EU Email	contact-emea@quidelortho.com

Specifications
Citations
Certificate of Analysis

Specifications

Description	The MicroVue Mouse PTH 1-84 ELISA Kit is for the measurement of PTH in mouse plasma or cell culture media.
Size	96 wells/test
Form	96 well plate with 12 eight-well strips in a resealable foil pouch
Specimen	Plasma or Cell Culture Supernatent, 25 μL
Limit of Detection (LOD)	0.004 ng/mL
Lower Limit of Quantitation (LLOQ)	0.004 ng/mL
Upper Limit of Quantitation (ULOQ)	N/A
Intra Assay	2.4 - 5.6%
Inter Assay	5.4 - 5.7%
Standards	6
Controls	2
Sample Values	N/A
Assay Time	3.5 hours
Cross Reactivity	Rat
Storage	Store unopened kit between 2°C to 8°C. Refer to manual for storing individual components
Background	Mouse intact parathyroid hormone (PTH 1-84) is an amino acid polypeptide produced by the parathyroid gland with its biological activity residing in the N-terminal region of the peptide. PTH plays an important role in maintaining the concentration of ionized calcium within the limits needed to achieve normal metabolic functions. When serum calcium levels are decreased the parathyroid gland increases secretion of the hormone which results in increased mobilization of calcium from skeletal reserves into the circulation. When levels of serum calcium are increased the secretion of PTH is reduced.

Citations

Title	Year	Applications	Sample Species	Sample	Sample Details
Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid-Induced AKI	2024	ELISA	Mouse	Plasma	Murine-Folic Acid-Induced Acute Kidney Injury
The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction	2017	ELISA	Mouse	Plasma
Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice.	2018	ELISA	Mouse	Plasma
Feature Article: Altered morpho-functional features of bones in autoimmune disease-prone BXSB/MpJ-Yaa mice.	2019	ELISA	Mouse	Serum
1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice	2019	ELISA	Mouse	Serum
1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice	2019	ELISA	Mouse	Urine
Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice.	2019	ELISA	Mouse	Plasma
Human Heterozygous ENPP1 Deficiency Is Associated With Early Onset Osteoporosis, a Phenotype Recapitulated in a Mouse Model of Enpp1 Deficiency.	2019	ELISA	Mouse	Plasma
Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia	2013	ELISA	Mouse	Serum
Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23	2015	ELISA	Mouse	Serum
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production	2016	ELISA	Mouse	Serum
Hypochlorhydria-induced calcium malabsorption does not affect fracture healing but increases post-traumatic bone loss in the intact skeleton	2016	ELISA	Mouse	Serum
Dietary phosphate supplement does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia	2016	ELISA	Mouse	Serum
Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid–Induced AKI	2024	ELISA	Mouse	Plasma	Murine-Folic Acid-Induced Acute Kidney Injury

Certificate of Analysis

Showing results for

No results found for

Avis juridique

En accédant, en naviguant ou en utilisant ce site Web, vous reconnaissez que vous avez lu, compris et accepté d’être lié par les Conditions d’utilisation du site Web et l’Avis de confidentialité de QuidelOrtho, et de vous conformer à toutes les lois et à tous les règlements applicables. Si vous n’acceptez pas ces conditions, veuillez ne pas utiliser le site Web. En outre, le site Web contient des informations sur les produits qui s’adressent à de nombreux publics différents et peuvent contenir des détails sur les produits ou des informations qui ne sont pas accessibles ou valables dans votre pays. La disponibilité des produits peut varier d’un pays à l’autre et est soumise à des exigences réglementaires variables. La nouvelle marque QuidelOrtho peut ne pas être disponible sur tous les marchés, sous réserve de l’approbation réglementaire propre à chaque pays. Veuillez noter que nous ne sommes pas responsables de votre accès à ces informations qui peuvent ne pas être conformes à une procédure légale, à une réglementation, à un enregistrement ou à un usage dans votre pays d’origine.

©2024 QuidelOrtho Corporation. Tous droits réservés.

QuidelOrtho Corporation
9975 Summers Ridge Road, San Diego, CA 92121, USA